Larvol Delta - Safety-and-Immunogenicity-of-VPM1002-Vaccination-or-BCG-Revaccination-Against-TB-in-PreAdolescents-Living-With-and-Without-HIV-in-South-Africa

VPM1002 - SAKK, Serum Institute of India

http://clinicaltrials.gov/ct2/show/NCT04351685

May 28, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next